Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants and Children

NCT01569581 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT01569581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01569581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants and Children
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
March 31, 2013
Enrollment
12,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the efficacy of inactivated ev71 vaccine (kmb17) against hfmd in chinese children and infants